Neuren Pharmaceuticals Ltd (NEU) — Free Cash Flow Generation Index
Neuren Pharmaceuticals Ltd (NEU) has a Free Cash Flow Generation Index of 1.00x as of June 2025. Free cash flow of AU$128.30 Million represents 1% of operating cash flow (AU$128.31 Million). Read debt load of Neuren Pharmaceuticals Ltd for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Neuren Pharmaceuticals Ltd Free Cash Flow Generation Index (2018–2023)
Historical FCF Generation Index trend for Neuren Pharmaceuticals Ltd across 3 annual periods. Explore NEU capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Neuren Pharmaceuticals Ltd (2018–2023)
Year-by-year Free Cash Flow Generation Index for Neuren Pharmaceuticals Ltd. For the full company profile including market capitalisation, see NEU market cap.
| Year | FCG Index | Free Cash Flow (AUD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.00x | AU$184.88 Million | AU$184.93 Million | AU$40.00K | ▲ +0.5% |
| 2022 | 0.99x | AU$3.58 Million | AU$3.60 Million | AU$19.00K | ▼ -0.5% |
| 2018 | 1.00x | AU$6.41 Million | AU$6.41 Million | AU$12.00K | — |